Laos , Thailand and Malaysia work together to study ways to improve the management of alcoholic hepatitis cases in the region.
Vision Times reported that participating countries shared the latest knowledge of hepatitis with Eurodrug, a Belgian pharmaceutical company, and discussed the benefits of using medoxin to treat patients with alcohol-related liver diseases.
Health professionals discussed the role of the drug medolin in the management of liver disease at a meeting earlier this month.
Dr. Sengdao Vannarath, an expert at Mahosu Hospital, said long-term alcohol consumption is one of the main causes of death from hepatitis and liver disease.
According to Dr Sengdao, although there are limited options for hepatitis treatment and prevention in Laos, most Lao people do not understand the drugs that can be used to treat alcoholic hepatitis and the methods to prevent alcoholic hepatitis. Ms. Htoo Htoo Mai, Asia Business Development Manager at
Eurodrug, told Metadoxine has been used in Malaysia and Europe to reduce alcohol cravings and consumption.
According to a study published in the British Journal of Medicine (BMJ) in 2011, the study of oral medolcin in patients with alcoholic liver disease showed positive results.
Director of the Medical Equipment and Drug Supply Center of the Ministry of Health said that companies have recently been approved to import Metadoxine for the treatment of alcoholic hepatitis.
viral hepatitis is the seventh leading cause of death in the world and the only infectious disease with rising mortality rates. Every year, viral hepatitis causes at least as many deaths as the combined number of deaths from tuberculosis, AIDS, and malaria.
